Stem Cell Research Goes Crimson: International Leader in Stem Cell Research Named New Dean of Harvard Medical School
George Q. Daley, MD, PhD, Harvard Medical School’s newly appointed dean, led dozens of international colleagues in developing ethical guidelines for stem cell research. On March 9, 2009, President Barack H. Obama issued Executive Order 13505: Removing Barriers to Responsible Scientific Research involving Human Stem Cells, stating that the Secretary of Health and Human Services, through
Alfredo Hoyos, M.D., Global Stem Cells Group’s chief scientific officer (CSO), is a renowned board-certified plastic surgeon from Bogotá, Colombia. Dr. Hoyos earned his medical degree at El Rosario University in Bogotá and performed his residency in plastic surgery at the Rosario – Saint Joseph Hospital, also in Bogotá. The inventor of High Definition Liposculpture (HDL), Dynamic
Global Stem Cells Group and N-Biotek Collaborate to Offer Turnkey Solutions for Highly Manipulated Stem Cell Culture Expansion Labs
MIAMI, Aug. 23, 2016 – Global Stem Cells Group and its subsidiary Adimarket announce a collaborative agreement with South Korean biomedical and lab equipment manufacturer N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total
Global Stem Cells Group has announced a stem cell training course in Madrid, Spain, to be held Dec. 6 – 7, 2016, in collaboration with Javier Garcia Alonso, MD and Clinica Castellana Norte. MIAMI, Aug. 16, 2016—Global Stem Cells Group and Stem Cell Training, Inc. will host a stem cell training course in Madrid, Dec. 6-7,
Global Stem Cells Group to Honor Joseph Purita, MD at 3rd Annual International Symposium on Stem Cells and Regenerative Medicine in Buenos Aires
Global Stem Cells Group will honor Joseph Purita, MD at its 3rd Annual International Symposium on Stem Cells and Regenerative Medicine, to be held in Buenos Aires Sept. 28, 2016. Purita, an active contributor to the Miami-based biotech company, has been a key participant in GSCG’s growth since it launched in 2013. MIAMI, Aug.
Julio Ferreira, M.D. Global Stem Cells Group Advisory Board member Julio Ferreira, M.D., is an internationally recognized and respected cosmetic surgeon and professor of medicine and aesthetic surgery at the Institute of Biomedical Sciences, University of Sao Paulo, Brazil; As director of Clinica Ferreira in Argentina, Dr. Ferreira is dedicated to the combination of art
Duncan Ross, Ph.D. Global Stem Cells Group Advisory Board member Duncan Ross, Ph.D., is a graduate of the University of Miami Immunology and Biochemistry departments where he specialized in stem cell transplantation and protein expression and purification. Dr. Ross has been featured in various peer reviewed publications including “Blood and the Biology of Blood.” and
Joseph Purita, M.D. Global Stem Cells Group Advisory Board member Joseph Purita, M.D., is a world-renowned orthopedic surgeon and stem cell pioneer, using cutting edge technology in regenerative medicine in conjunction with stem cell platelet rich plasma (PRP) therapy to treat orthopedic injuries and relieve pain. He is also a pioneer in the use of the
Global Stem Cells Group and its subsidiary Stem Cell Training, Inc., have announced plans to hold a stem cell training course in Barcelona, Spain, Nov. 11 – 12, 2016. Orthopedic and cosmetic surgeon J. Victor Garcia Gimenez, M.D. will conduct the course for qualified physicians and medical professionals. MIAMI, Aug. 10, 2016–Global Stem Cells Group
Chuck Dandridge, a Mansfield, Texas resident, became the first adult in the U.S. to receive a newly modified stem cell transplant that uses genetically engineered blood cells from a family member. The milestone was announced by researchers at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center in Dallas, where the procedure was performed.